Scilex Holding Co

SCLXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$30.3M

▼ 46.5% YoY

Net Income

-$374.1M

▼ 413.8% YoY

EPS

$-36.48

▼ 353.2% YoY

Cash

$5.0M

▲ 51.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.